Animal and human studies have shown an increased level of inflammatory mediators and prostaglandins (PGs) in the vitreous cavity of patients with diabetic retinopathy and that the vitreous level of prostaglandin PGE2 is directly related to that of vascular endothelial growth factor (VEGF) [4, 5]. Here, VEGFA is linked to diabetic retinopathy.